Geoffrey F. Cox Ph.D., Chairman
Dr. Cox has over 35 years of pharmaceutical and biotechnology experience in a broad range of senior management positions in operations management, as a CEO and as a member of the board of public and private companies.
In 1984, Dr. Cox joined Genzyme Corporation in the U.K. and then, in 1988, became Senior Vice President, Operations in the U.S. Dr. Cox later became Executive Vice President responsible for operations and the pharmaceutical, diagnostic and genetics business units of Genzyme. Prior to joining Genzyme, Dr. Cox was General Manager of the U.K. manufacturing operations for Gist-Brocades.
In 1997, Dr. Cox became Chairman and CEO of Aronex Pharmaceuticals, Inc., based in The Woodlands, Texas, and subsequently, in July 2001, he became Chairman, President and CEO of GTC Biotherapeutics,Inc., based in Framingham, Massachusetts, a position he held until June 2010.
In October 2011, Dr. Cox became a Partner in Red Sky Partners LLC, a life sciences advisory company based in Cambridge, Massachusetts.
Dr. Cox serves as a Director on the Board of Biota Pharmaceuticals Inc. and as a Director on the Board of QLT Inc. He is also a Director of Gallus Biopharmaceuticals. He is the immediate past Chairman of the Board of MassBio, the Massachusetts Biotechnology Council and also served for a number of years on the Board of the Biotechnology Industry Organization and as a member of their Emerging Companies Section and Healthcare Section Governing Body Committees.
Dr. Cox received a B.Sc.(Hons) in Biochemistry from the University of Birmingham, U.K. and a Ph.D. in Biochemistry from the University of East Anglia, U.K.